John Paul II Hospital, Krakow   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Kraków Poland

Organization Overview

First Clinical Trial
2007
NCT00503529
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Department of Cardiovascular Surgery and Transplantology, John Paul II Hospital | Department of Interventional Cardiology, John Paul II Hospital | John Paul II Hospital | John Paul II Hospital, Krakow | Karol Wierzbicki | The John Paul II Hospital, Krakow, Poland

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Encephalitis (Phase 4)

Encephalitis, Tick-Borne (Phase 4)

Heart Failure (Phase 3)

Infarction (Phase 3)

Ischemia (Phase 3)

Myocardial Infarction (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 7